| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Division of Applied Toxicology, Institute of Toxicology, University of Mainz, D-55131 Mainz, Germany [M. T. T., B. K.]; Institute for Antiviral Chemotherapy, Friedrich Schiller University, D-07745 Jena, Germany [R. T.]; and Laboratory of Structural Biology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [R. W. S.]
The efficacy of suicide herpes simplex virus-1 thymidine kinase (HSVtk)/ganciclovir (GCV) gene therapy is often limited by intrinsic resistance of tumor cells. Here we show that repair of GCV incorporated in DNA is a factor involved in GCV resistance. A protective role of DNA repair in GCV-induced cell killing is supported by the following findings: (a) GCV-exposed Chinese hamster ovary-HSVtk cells exhibited both reduced repair of GCV and cloning efficiency in the presence of a specific polymerase ß (ß-pol) inhibitor, prunasin; (b) DNA ß-pol-deficient mouse fibroblasts were more sensitive to the cytotoxic, apoptosis-inducing, and genotoxic (DNA breakage and chromosomal aberration-inducing) effects of GCV as compared with wild-type and ß-pol-complemented cell lines; (c) methoxyamine, an inhibitor of ß-pol-dependent short-patch base excision repair, sensitized wild-type and complemented ß-pol cells to GCV, whereas it had no effect on the sensitivity of ß-pol-null cells to GCV. Because methoxyamine-mediated sensitization of ß-pol wild-type and ß-pol-complemented cells to GCV did not reach the level of null cells, we suggest that both ß-pol-dependent short- and long-patch base excision repair are involved in protection of cells to GCV. Some implications for HSVtk/GCV gene therapy are being discussed.
This article has been cited by other articles:
![]() |
M. Christmann, M. T. Tomicic, J. Origer, D. Aasland, and B. Kaina c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF Nucleic Acids Res., December 2, 2006; 34(22): 6530 - 6539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K.L. Chan, Q.-M. Zhang, and G. L. Dianov Base excision repair fidelity in normal and cancer cells Mutagenesis, May 1, 2006; 21(3): 173 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Henikoff Rapid Changes in Plant Genomes PLANT CELL, November 1, 2005; 17(11): 2852 - 2855. [Full Text] [PDF] |
||||
![]() |
R. Thust, M.T. Tomicic, R. Grabner, C. Friedrichs, P. Wutzler, and B. Kaina Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells Mutagenesis, January 1, 2004; 19(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Taverna, H.-s. Hwang, J. E. Schupp, T. Radivoyevitch, N. N. Session, G. Reddy, D. A. Zarling, and T. J. Kinsella Inhibition of Base Excision Repair Potentiates Iododeoxyuridine-induced Cytotoxicity and Radiosensitization Cancer Res., February 15, 2003; 63(4): 838 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tomicic, C. Friedrichs, M. Christmann, P. Wutzler, R. Thust, and B. Kaina Apoptosis Induced by (E)-5-(2-Bromovinyl)-2'-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8 Mol. Pharmacol., February 1, 2003; 63(2): 439 - 449. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |